Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7204)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2015 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marks EI, Yee NS. Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies. World J Gastrointest Oncol 2015; 7(11): 338-346 [PMID: 26600933 DOI: 10.4251/wjgo.v7.i11.338] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i11/338.htm |
| Number | Citing Articles |
| 1 |
Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution. Cancer Research and Treatment 2017; 49(2): 473 doi: 10.4143/crt.2016.166
|
| 2 |
Oraianthi Fiste, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Michalis Liontos, Konstantinos Koutsoukos, Meletios Athanasios Dimopoulos, Flora Zagouri. The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma. Vaccines 2021; 9(5): 422 doi: 10.3390/vaccines9050422
|
| 3 |
Xianzhe Yu, Lingling Zhu, Ting Wang, Jiang Chen. Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1037945
|
| 4 |
Anna Kasperska, Jędrzej Borowczak, Krzysztof Szczerbowski, Ewa Stec, Navid Ahmadi, Łukasz Szylber. Current Challenges in Targeting Tumor Desmoplasia to Improve the Efficacy of Immunotherapy. Current Cancer Drug Targets 2021; 21(11): 919 doi: 10.2174/1568009621666210825101456
|
| 5 |
Amir A. Rahnemai-Azar, Allison B. Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: current management and emerging therapies. Expert Review of Gastroenterology & Hepatology 2017; 11(5): 439 doi: 10.1080/17474124.2017.1309290
|
| 6 |
Amit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, Gaurav Goyal, Tushar C. Patel, Candice A. Bookwalter, Sean P. Cleary, Christopher L. Hallemeier, Rondell P. Graham. Evaluation and Management of Liver Masses. 2020; : 229 doi: 10.1007/978-3-030-46699-2_11
|
| 7 |
Alex B. Blair, Adrian Murphy. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future. Current Problems in Cancer 2018; 42(1): 49 doi: 10.1016/j.currproblcancer.2017.10.004
|
| 8 |
Amit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, Alexander Lim, Richard Kim. Novel targeted treatment options for advanced cholangiocarcinoma. Expert Opinion on Investigational Drugs 2018; 27(9): 709 doi: 10.1080/13543784.2018.1512581
|
| 9 |
Ningyu Wang, Ai Huang, Bohua Kuang, Yu Xiao, Yong Xiao, Hong Ma. Progress in Radiotherapy for Cholangiocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.868034
|
| 10 |
Bonala Sabeerabi, Venkat R. Arva Tatireddygari, Ramakrishna Vadde. Immunotherapy for Gastrointestinal Malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 113 doi: 10.1007/978-981-15-6487-1_8
|
| 11 |
Piamsiri Sawaisorn, Ahmed Gaballa, Kween Saimuang, Chaniya Leepiyasakulchai, Sakaorat Lertjuthaporn, Suradej Hongeng, Michael Uhlin, Kulachart Jangpatarapongsa. Human Vγ9Vδ2 T cell expansion and their cytotoxic responses against cholangiocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51794-1
|
| 12 |
Alphonse Charbel, Luca Tavernar, Thomas Albrecht, Fritz Brinkmann, Joanne Verheij, Eva Roos, Monika Nadja Vogel, Bruno Köhler, Christoph Springfeld, Alexander Brobeil, Peter Schirmacher, Stephan Singer, Arianeb Mehrabi, Stephanie Roessler, Benjamin Goeppert. Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis. British Journal of Cancer 2022; 127(9): 1603 doi: 10.1038/s41416-022-01933-0
|
| 13 |
Haihong Cheng, Di Zhou, Shouhua Wang, Jun Ding, Fei Ma. The immunological characteristics of gallbladder carcinoma and advances in immunotherapy practices. BioScience Trends 2021; 15(1): 9 doi: 10.5582/bst.2020.01039
|
| 14 |
Yanjun Sun, Junfeng Gong, Zhuang Li, Lin Han, Dengqun Sun. Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy. Postgraduate Medicine 2024; doi: 10.1080/00325481.2024.2345585
|
| 15 |
Shuting Han, Suat Ying Lee, Who-Whong Wang, Yu Bin Tan, Rachel Hui Zhen Sim, Rachael Cheong, Cherlyn Tan, Richard Hopkins, John Connolly, Wai Ho Shuen, Han Chong Toh. A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs). Cancers 2020; 12(11): 3404 doi: 10.3390/cancers12113404
|
| 16 |
Toshifumi Wakai, Masayuki Nagahashi, Yoshifumi Shimada, Pankaj Prasoon, Jun Sakata. Genetic analysis in the clinical management of biliary tract cancer. Annals of Gastroenterological Surgery 2020; 4(4): 316 doi: 10.1002/ags3.12334
|
| 17 |
Raed Al-Rajabi, Weijing Sun. Immunotherapy in cholangiocarcinoma. Current Opinion in Gastroenterology 2021; 37(2): 105 doi: 10.1097/MOG.0000000000000715
|
| 18 |
Lionel A. Kankeu Fonkoua, Pedro Luiz Serrano Uson Junior, Kabir Mody, Amit Mahipal, Mitesh J. Borad, Lewis R. Roberts. Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications. Expert Opinion on Therapeutic Targets 2022; 26(1): 79 doi: 10.1080/14728222.2022.2029412
|
| 19 |
Nelson Yee, Eugene Lengerich, Kathryn Schmitz, Jennifer Maranki, Niraj Gusani, Leila Tchelebi, Heath Mackley, Karen Krok, Maria Baker, Claire Boer, Julian Yee. Frontiers in Gastrointestinal Oncology: Advances in Multi-Disciplinary Patient Care. Biomedicines 2018; 6(2): 64 doi: 10.3390/biomedicines6020064
|
| 20 |
Urvi A. Shah, Amara G. Nandikolla, Lakshmi Rajdev. Immunotherapeutic Approaches to Biliary Cancer. Current Treatment Options in Oncology 2017; 18(7) doi: 10.1007/s11864-017-0486-9
|
| 21 |
Joseph Ho, Constance Fiocco, Kristen Spencer. Treating Biliary Tract Cancers: New Targets and Therapies. Drugs 2022; 82(17): 1629 doi: 10.1007/s40265-022-01808-x
|
| 22 |
Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda. Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer. Journal for ImmunoTherapy of Cancer 2020; 8(1): e000564 doi: 10.1136/jitc-2020-000564
|
| 23 |
Yuhao Zhao, Mao Yang, Jiayi Feng, Xu'an Wang, Yingbin Liu. Advances in immunotherapy for biliary tract cancers. Chinese Medical Journal 2024; 137(5): 524 doi: 10.1097/CM9.0000000000002759
|
| 24 |
Wen-Hui Luo, Shao-Jun Li, Xue-Feng Wang. Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature. World Journal of Gastrointestinal Oncology 2023; 15(11): 2033-2040 doi: 10.4251/wjgo.v15.i11.2033
Abstract(164) |
Core Tip(147) |
Full Article(HTML)(566)
|
Full Article with Cover (PDF)-5685K(21)
|
Full Article (Word)-2654K(12)
|
Audio-2199K(0)
|
Peer-Review Report-234K(17)
|
Answering Reviewers-101K(14)
|
Full Article (PDF)-5392K(32)
|
Full Article (XML)-87K(13)
|
Times Cited (0)
|
Total Visits (1966)
|
Open
|
| 25 |
Tiantian Wu, Changsheng Pu, Qiang Wang, Keming Zhang. Comparison of Efficacy and Safety of Anti-Programmed Cell Death-1 Antibody Plus Lenvatinib and Chemotherapy as First-Line Therapy for Patients with Stage IV Gallbladder Cancer: A Real-World Study in a Chinese Population. Biomedicines 2023; 11(11): 2933 doi: 10.3390/biomedicines11112933
|
| 26 |
Sean Turbeville, Carl S. Hornfeldt, Milind Javle, Eric Tran, Marion Schwartz. Emerging therapies for the treatment of cholangiocarcinoma. International Journal of Hepatobiliary and Pancreatic Diseases 2017; 7(2): 36 doi: 10.5348/ijhpd-2017-72-RA-8
|
| 27 |
Li-ming Zhao, An-da Shi, Yan Yang, Zeng-li Liu, Xiao-Qiang Hu, Li-Zhuang Shu, Yong-chang Tang, Zong-li Zhang. Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1140103
|
| 28 |
Juan W. Valle, Angela Lamarca, Lipika Goyal, Jorge Barriuso, Andrew X. Zhu. New Horizons for Precision Medicine in Biliary Tract Cancers. Cancer Discovery 2017; 7(9): 943 doi: 10.1158/2159-8290.CD-17-0245
|
| 29 |
Luxi Yin, Qi Xu, Jingjing Li, Qing Wei, Jieer Ying. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer. Medicine 2018; 97(50): e13570 doi: 10.1097/MD.0000000000013570
|
| 30 |
Aileen Deng, Steven Cohen. Primary and Metastatic Liver Tumors. 2018; : 137 doi: 10.1007/978-3-319-91977-5_11
|
| 31 |
A. M. Matilla Peña, A. Clemente Sánchez, E. Ramón Botella, D. Rincón. Colangiocarcinoma. Medicine - Programa de Formación Médica Continuada Acreditado 2020; 13(12): 666 doi: 10.1016/j.med.2020.06.020
|
| 32 |
Cecilia Monge, Erica C Pehrsson, Changqing Xie, Austin G Duffy, Donna Mabry, Bradford J Wood, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, Tim F Greten. A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma. The Oncologist 2022; 27(3): e273 doi: 10.1093/oncolo/oyab073
|
| 33 |
Muzaffer Uğraklı, Mustafa Karaağaç, Mehmet Artaç. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_218-1
|
| 34 |
Anwaar Saeed, Robin Park, Mohammed Al-Jumayli, Raed Al-Rajabi, Weijing Sun. Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma. Clinical Colorectal Cancer 2019; 18(2): 81 doi: 10.1016/j.clcc.2019.02.005
|